Related Experiment Videos
[Pharmacovigilance IV. The institutional experience].
David L Hernández Santillán1, Leticia Rodríguez Betancourt, Luis Jasso Gutiérrez
1Programa Institucional de Farmacovigilancia, División Institutional de Cuadros Básicos de Insumos para la Salud Instituto Mexicano del Seguro Social.
Revista Medica Del Instituto Mexicano Del Seguro Social
|September 6, 2005
Summary
This study analyzed 890 adverse drug reaction reports from 2003, finding antibiotics and antiparasitics most common. Institutional and international pharmacovigilance data showed similar trends in drug reactions.
Area of Science:
- Pharmacovigilance
- Drug Safety Monitoring
- Clinical Pharmacology
Context:
- Presents institutional pharmacovigilance data from 2003.
- Compares institutional adverse drug reaction (ADR) reports with international trends.
- Highlights the importance of ongoing drug safety surveillance.
Purpose:
- To report institutional experience with 890 ADRs in 2003.
- To compare institutional ADR data with international pharmacovigilance findings.
- To identify frequently implicated drug classes, specific drugs, and clinical manifestations.
Summary:
- Antibiotic and antiparasitic drugs were most frequently reported (38.2%), followed by oncologic and analgesic agents.
- Sulfamethoxazole-trimethoprim was the most implicated drug (12%).
- Skin was the most affected organ system (874 reports), with most ADRs being mild (68.7%).
Impact:
- Provides insights into drug safety profiles within a specific institutional context.
- Facilitates comparison of local drug reaction patterns with global trends.
- Informs healthcare professionals and regulatory bodies about potential drug risks and monitoring needs.